Patients with cancer may have potentially curable disease or may live for many years despite incurable cancer. However, these guidelines specifically relate to patients with advanced incurable cancer who are expected to live for a few months or less. Distinction is made between patients with a few months to live, who may or may not be receiving anticancer therapies, and those thought to be imminently dying (i.e. within days or weeks). This guideline focuses on the prediction of death or length of survival and not other clinically-important outcomes such as response to treatment, preferred place of death or length of inpatient stay. Recommendations are provided to health care professionals (HCPs) who care for patients with advanced cancer in the last months of life regarding the best way to prognosticate and to communicate prognoses to patients and their families or caregivers. A proposed algorithm for prognostication and communication is shown in Figure 1.

Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline / Stone, P.; Buckle, P.; Dolan, R.; Feliu, J.; Hui, D.; Laird, B. J. A.; Maltoni, M.; Moine, S.; Morita, T.; Nabal, M.; Vickerstaff, V.; White, N.; Santini, D.; Ripamonti, C. I.. - In: ESMO OPEN. - ISSN 2059-7029. - 8:2(2023). [10.1016/j.esmoop.2023.101195]

Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline

Feliu, J.;Santini, D.;
2023

Abstract

Patients with cancer may have potentially curable disease or may live for many years despite incurable cancer. However, these guidelines specifically relate to patients with advanced incurable cancer who are expected to live for a few months or less. Distinction is made between patients with a few months to live, who may or may not be receiving anticancer therapies, and those thought to be imminently dying (i.e. within days or weeks). This guideline focuses on the prediction of death or length of survival and not other clinically-important outcomes such as response to treatment, preferred place of death or length of inpatient stay. Recommendations are provided to health care professionals (HCPs) who care for patients with advanced cancer in the last months of life regarding the best way to prognosticate and to communicate prognoses to patients and their families or caregivers. A proposed algorithm for prognostication and communication is shown in Figure 1.
2023
advanced cancer, ESMO Clinical Practice Guideline, palliative care, prognostic factors, risk prediction models
01 Pubblicazione su rivista::01a Articolo in rivista
Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline / Stone, P.; Buckle, P.; Dolan, R.; Feliu, J.; Hui, D.; Laird, B. J. A.; Maltoni, M.; Moine, S.; Morita, T.; Nabal, M.; Vickerstaff, V.; White, N.; Santini, D.; Ripamonti, C. I.. - In: ESMO OPEN. - ISSN 2059-7029. - 8:2(2023). [10.1016/j.esmoop.2023.101195]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1705078
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 19
social impact